[1]
A. B. Kimball, “Long-term Impact of Ixekizumab on Psoriasis Itch Severity: Results from a Phase III Clinical Trial and Long-term Extension”, Acta Derm Venereol, vol. 98, no. 1, pp. 98–102, Oct. 2017.